Literature DB >> 9875078

Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter.

K Greaves1, T Crake.   

Abstract

OBJECTIVE: To determine whether cardiac troponin T increases after electrical cardioversion in patients with atrial fibrillation or atrial flutter.
DESIGN: Serum creatine kinase (CK), creatine kinase-MB (CKMB), and cardiac troponin T were measured before, 24 hours, and 48 hours after cardioversion in 15 patients with atrial fibrillation or atrial flutter.
RESULTS: 12 of the 15 patients (80%) were successfully cardioverted to sinus rhythm. The median number of shocks was three (range one to six), the median cumulative energy 710 J (50 to 1430 J), and the median peak energy 300 J (50 to 360 J). Total CK increased from a baseline median concentration of 92 (45 to 259) to 1324 (96 to 6660) U/l at 24 hours and 1529 (120 to 4774) U/l at 48 hours after cardioversion. There was a small increase in CKMB but the ratio of CKMB to CK did not increase. There was no increase in cardiac troponin T in any patient.
CONCLUSIONS: Following electrical cardioversion of atrial fibrillation or atrial flutter, cardiac troponin T remains unchanged despite a large rise in total CK, indicating that the CK is derived from skeletal muscle and that myocardial injury does not occur. If cardiac troponin T is increased after cardioversion for atrial arrhythmias then other causes of myocardial damage should be sought.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875078      PMCID: PMC1761086          DOI: 10.1136/hrt.80.3.226

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  14 in total

1.  Development and in vitro characterization of a new immunoassay of cardiac troponin T.

Authors:  H A Katus; S Looser; K Hallermayer; A Remppis; T Scheffold; A Borgya; U Essig; U Geuss
Journal:  Clin Chem       Date:  1992-03       Impact factor: 8.327

2.  Enzyme release after elective cardioversion.

Authors:  J Jakobsson; I Odmansson; R Nordlander
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

3.  Origin of elevated serum enzyme activities after direct-current countershock.

Authors:  A Konttinen; V Hupli; A Louhija; G Härtel
Journal:  N Engl J Med       Date:  1969-07-31       Impact factor: 91.245

4.  Does cardioversion of atrial fibrillation result in myocardial damage?

Authors:  M J Metcalfe; F Smith; K Jennings; N Paterson
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-14

5.  Effects of electrical countershock on serum creatine phosphokinase (CPK) isoenzyme activity.

Authors:  A Ehsani; G A Ewy; B E Sobel
Journal:  Am J Cardiol       Date:  1976-01       Impact factor: 2.778

6.  Estimation of acute myocardial infarct size in man by serum CK-MB measurements.

Authors:  P Grande; B F Hansen; C Christiansen; J Naestoft
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

7.  Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.

Authors:  E M Ohman; P W Armstrong; R H Christenson; C B Granger; H A Katus; C W Hamm; M A O'Hanesian; G S Wagner; N S Kleiman; F E Harrell; R M Califf; E J Topol
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

8.  Creatine phosphokinase isozymes in muscles. Human fetus and patients.

Authors:  I Goto; M Nagamine; S Katsuki
Journal:  Arch Neurol       Date:  1969-04

9.  Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio.

Authors:  M el Allaf; J P Chapelle; D el Allaf; A Adam; M E Faymonville; P Laurent; C Heusghem
Journal:  Clin Chem       Date:  1986-02       Impact factor: 8.327

10.  Time course of creatine kinase release after termination of sustained ventricular dysrhythmias.

Authors:  P G O'Neill; L Faitelson; A Taylor; P Puleo; R Roberts; A Pacifico
Journal:  Am Heart J       Date:  1991-09       Impact factor: 4.749

View more
  1 in total

1.  Higher energy monophasic DC cardioversion for persistent atrial fibrillation: is it time to start at 360 joules?

Authors:  C Boos; M D Thomas; A Jones; E Clarke; G Wilbourne; R S More
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.